Oncology & Cancer Treatment in Erbil: What Patients Need to Know (2026)

A cancer diagnosis is one of the most disorienting experiences a person can face. In Erbil, that disorientation has historically been compounded by the knowledge that many cancers could not be adequately treated locally — patients and families faced the prospect of traveling abroad for care, often at great financial and personal cost, or accepting treatment of uncertain quality within Iraq.

That picture has been changing. While Kurdistan's oncology infrastructure remains behind global centers of excellence, the gap has narrowed considerably over the past decade. Erbil now has dedicated oncology departments, functional chemotherapy units, and radiotherapy capability. Local oncologists are better trained, newer medicines are available, and diagnostic technology has improved.

This guide maps the current state of cancer care in Erbil in 2026 — what is genuinely available locally, what still requires travel abroad, how to find oncology specialists, and what practical steps families should take when navigating a cancer diagnosis in Kurdistan.

---

The Current State of Cancer Care in Kurdistan

Kurdistan faces cancer at increasing rates, consistent with a regional and global pattern driven by lifestyle changes: tobacco use remains high among Kurdish men, obesity is increasing, and improvements in primary healthcare mean that conditions that would have gone undiagnosed a generation ago are now detected. According to WHO data and KRG health ministry reports, cancer is the second leading cause of death in Iraq after cardiovascular disease.

Historically, Kurdistan's cancer care was fragmented and underfunded. The Iraq Cancer Registry documented the epidemiology, but treatment infrastructure was concentrated in Baghdad and could not meet even that city's needs. Kurdistan patients with means traveled to Iran, Jordan, Turkey, or Europe for treatment. Those without means received what was available locally, which was often inadequate.

Today, the situation is meaningfully better:

• Erbil has functional oncology departments in its major hospitals
• Chemotherapy infusion units exist and are generally well-equipped
• Linear accelerator (LINAC) radiotherapy is available in Erbil
• Pathology and molecular diagnostic services have improved, enabling better cancer diagnosis and subtyping
• A small but growing community of Kurdistan-trained oncologists has returned from abroad or trained locally with international supervision

---

Key Oncology Facilities in Erbil

Erbil Teaching Hospital — Oncology Department

The Erbil Teaching Hospital, operated under the KRG Ministry of Health, hosts the Kurdistan's largest public oncology department. The department provides chemotherapy, hormone therapy, and supportive care, and accepts patients from across the Kurdistan Region and beyond. As a public facility, costs are subsidized or free for Iraqi citizens, making it the primary access point for patients without private healthcare coverage.

Waiting times at the public oncology department can be significant, and the volume of patients relative to staffing is a persistent challenge. Patients with resources often pursue parallel private consultations while waiting for public system appointments.

Hawler Private Hospital

[Hawler Private Hospital](/hawler-private-hospital-erbil) has developed one of the more comprehensive oncology programs in the private sector, with a dedicated oncology wing, chemotherapy unit, and consulting oncologists who hold board certifications from international institutions. The hospital has invested in diagnostic imaging capabilities — including PET-CT scanning, which is essential for accurate cancer staging — that are not universally available in Erbil.

Kurdistan Center for Gastroenterology and Hepatology

Gastrointestinal cancers — colorectal cancer, hepatocellular carcinoma (liver cancer), stomach cancer, and pancreatic cancer — are among the most prevalent cancer types in Kurdistan. Specialized centers with gastroenterology expertise provide endoscopic evaluation, biopsy capability, and coordination with oncology for treatment planning.

Zheen International Hospital

[Zheen International Hospital](/zheen-international-hospital-erbil) has positioned itself as a higher-end private facility with broader specialist capability. Its oncology consultants include physicians with international training credentials, and the hospital coordinates international second opinions and referrals for patients whose cases exceed local treatment capability.

The Breast Cancer Screening and Treatment Programs

Breast cancer is the most common cancer among women in Kurdistan. Several dedicated breast health programs have emerged in Erbil, combining mammography screening with rapid assessment pathways for detected abnormalities. These programs represent a meaningful public health advance — earlier detection leads directly to better treatment outcomes, and the normalization of screening is changing survival rates for breast cancer in Erbil.

---

Diagnostic Services: The Foundation of Cancer Care

Accurate diagnosis is the prerequisite for appropriate treatment. Kurdistan's diagnostic capabilities have improved but remain an area of active development.

Pathology and Histology

Cancer diagnosis requires tissue biopsy with pathological analysis — examining cells under a microscope to confirm malignancy, determine cancer type, and grade the tumor. Erbil's hospital pathology laboratories are generally capable for routine cancer diagnoses. For rare tumors or cases where the pathological diagnosis is uncertain, samples can be sent to reference laboratories in Iraq, Jordan, Turkey, or internationally for second-opinion analysis.

Molecular and Genetic Testing

Modern cancer treatment increasingly depends on molecular profiling — testing tumor tissue for specific genetic mutations or protein markers that guide treatment selection. For example:

• Breast cancer is tested for HER2 receptor status and hormone receptor status, which determine whether targeted therapies (trastuzumab, endocrine therapy) will be effective
• Lung cancer is tested for EGFR mutations and ALK rearrangements, which predict response to specific targeted oral therapies
• Colorectal cancer is tested for KRAS and NRAS mutations, affecting treatment choices

Molecular testing capability in Erbil has expanded, with some tests now performable locally and others sent to reference laboratories in Baghdad, Jordan, or Turkey. The turnaround time for tests sent abroad can delay treatment initiation — something patients and oncologists need to plan for.

Imaging

---

Treatment Modalities Available Locally

Chemotherapy

Systemic chemotherapy — intravenous infusion or oral chemotherapy drugs — is the most established cancer treatment available in Erbil. The major private hospitals and the public oncology department have infusion units with trained nursing staff and pharmacy services to prepare chemotherapy. The range of chemotherapy agents available has expanded considerably and covers the standard regimens for the most common cancers.

Key questions to ask any oncology unit before treatment:

• What chemotherapy protocols do you use, and are they consistent with international guidelines (NCCN, ESMO)?
• How do you handle chemotherapy-related emergencies such as febrile neutropenia?
• What supportive medications (antiemetics, growth factors) are available alongside chemotherapy?

Targeted Therapy and Immunotherapy

Targeted therapies — drugs that act on specific molecular targets in cancer cells — and immunotherapy (checkpoint inhibitors that help the immune system fight cancer) represent the most significant advance in cancer treatment over the past two decades. These drugs are often taken orally and have transformed outcomes in cancers including lung, melanoma, kidney, and bladder cancer.

Availability of targeted therapies in Erbil has improved but remains inconsistent. Some agents are available through private hospital pharmacy import or through approved distribution networks; others require patients to source medications from abroad or through specialized importers. The cost of these drugs — often very high before patent expiration — is a significant barrier, as insurance coverage varies.

Biosimilar versions of established targeted therapies (trastuzumab biosimilars for HER2-positive breast cancer, for example) have become available and are substantially cheaper than originator products, improving access.

Radiation Therapy

Radiation therapy is available in Erbil, which represents a significant advance over the situation a decade ago when Kurdistan patients requiring radiotherapy had to travel to Baghdad or abroad. Linear accelerator (LINAC) technology allows precise delivery of radiation doses to tumor tissue while sparing surrounding normal structures.

Erbil's radiotherapy capacity remains limited relative to need. Treatment slots are constrained, and waiting times can be extended. For urgently needed radiotherapy — treating bone metastases causing severe pain, for example, or treating brain metastases — the lack of rapid access can be a meaningful clinical problem.

For complex radiotherapy techniques — stereotactic radiosurgery, IMRT for complex anatomical situations, proton therapy — referral to centers in Turkey, Jordan, or further afield remains appropriate.

Surgery

Surgical treatment for many solid tumors — breast cancer, colorectal cancer, thyroid cancer, early-stage lung cancer, kidney cancer — is well-established in Erbil's hospital sector. General and specialized surgeons operate at both public and private facilities. Robotic-assisted surgery, which offers precision advantages for prostate, gynecological, and some thoracic cancers, has been introduced at one or two Erbil facilities.

For highly specialized surgical procedures — hepatic resection for liver metastases, complex thoracic surgery, unusual tumor resections — referral to higher-volume centers outside Kurdistan is often appropriate. Surgical outcomes in oncology correlate with procedure volume: surgeons and hospitals doing more of a specific procedure do it better.

---

When to Consider Treatment Abroad

For some cancer diagnoses, local treatment is the right choice — standard cases of breast cancer, colorectal cancer, and other common tumors can be excellently managed in Erbil's better facilities. For others, accessing international care is genuinely important for outcomes.

Consider seeking international consultation or treatment when:

• The diagnosis is rare or unusual — tumors that Erbil oncologists see infrequently may be better managed at specialist centers where clinical volume gives the team deeper experience
• The treatment required is not locally available — proton therapy, certain specialized surgical techniques, CAR-T cell therapy for blood cancers, and some clinical trials are only accessible internationally
• The case is complex — locally treated patients who are not responding as expected, whose cancer has relapsed after initial treatment, or whose situation involves unusual clinical features benefit from expert second opinion
• Molecular testing identifies an actionable mutation — if testing reveals a specific mutation for which a targeted therapy exists but the drug is not accessible in Erbil, pursuing access abroad may dramatically affect prognosis

Turkey — particularly centers in Ankara, Istanbul, and Antalya — is the most common international referral destination for Kurdistan cancer patients due to geographic proximity, direct flight connections, and lower cost than Western European destinations. Jordan (King Hussein Cancer Center in Amman is highly regarded) and Germany are also common choices for specific cancer types.

---

Navigating a Cancer Diagnosis in Erbil: Practical Steps

---

Support Resources for Cancer Patients in Erbil

The practical and emotional support needs of cancer patients extend well beyond medical treatment. In Erbil:

• Social workers at major hospitals can help navigate insurance, financial assistance, and community support
• Patient advocacy groups for specific cancer types (breast cancer patient groups are the most established) offer peer support and information sharing
• Pharmacist consultation on managing chemotherapy side effects — nausea, fatigue, mouth sores, appetite loss — can meaningfully improve quality of life during treatment

The [Erbil medical directory](/) lists oncology departments, cancer specialists, and supporting services for patients navigating cancer care in Kurdistan.

--- Looking for oncology specialists or cancer treatment centers in Erbil? Browse the [Erbil medical directory](/) for hospitals and clinics with verified oncology services.